Blogs

Categories

Select a Sub-Category

Icon
Films and Coatings
vail 4ml
Pharmaceutical Packaging Components
Icon
Prefillable Systems
Icon
Self Injection Devices
Icon
Vial Containment Solutions
Icon
Washing and Sterilization
Icon
Reconstitution and Transfer Devices

Select a Sub-Category

Icon
Analytical Lab Services
Icon
Contract Manufacturing
Icon
Fill-Finish
Icon
Regulatory Support

Select a Sub-Category

Icon
Cell and Gene Therapy Packaging
Icon
Drug Development Process
Icon
Regulatory Challenges
Icon
Transitioning to Combination Products

Select a Sub-Category

Icon
Corporate Development
Icon
ESG/Sustainability
Icon
One West Team (Employee Culture)
Icon
Our Culture of Giving (Philanthropy)
Icon
Research and Development

Previous Blogs

Scientist conducting extractables and leachables testing in a West's laboratory

By Will Parker

January 21, 2025

In 21 CFR 211.94 it is stated that “Drug product containers and closures shall not be reactive, additive, or absorptive to alter the safety, identity, strength, quality or purity of the drug beyond the official or established requirements.” While the code makes this statement, and if expanded on in the related FDA Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics (May 1999), there is no prescription offered in how to execute an extractables and leachables evaluation, which is, of course, an essential aspect of demonstrating suitability of container closure systems.

Array of Corning Valor Glass Vials with caps, illustrating strength and efficiency in pharmaceutical packaging

By Mary Tan

January 16, 2025

Traditional borosilicate glass vials, while being a long-standing staple in pharmaceutical packaging, can present certain limitations that may pose some challenges to drug manufacturers and healthcare providers.

West technician performing container closure integrity testing on a sterile vial using advanced laboratory equipment.

By Victoria Morgan

January 08, 2025

In August 2022 the European Union revised its guidelines for sterile medicinal products for human and veterinary use. These guidelines came into effect on August 25, 2023. West has compiled the most frequently asked questions about Annex 1 and how it affects sterile drug manufacturers, which will be published across a multi-part series.

Scientist in a laboratory analyzing data on a computer for Leachables method validation

By Will Parker

December 19, 2024

This is part three of a three-part series about how recent updates to ICH Q2 and Q14 can be applied to the development and validation of leachables methods. Check out part one focused on the background and history of the updated ICH references and two focused on method development.

Technician operating advanced barrier technology equipment in a sterile manufacturing facility, aligning with EU GMP Annex 1 guidelines.

By Victoria Morgan

December 03, 2024

In August 2022 the European Union revised its guidelines for sterile medicinal products for human and veterinary use. These guidelines came into effect on August 25, 2023. West has compiled the most frequently asked questions about Annex 1 and how it affects sterile drug manufacturers, which will be published across a multi-part series.

West Taiwan team receiving the Work-Life Balance Award from the Ministry of Labor

By Eecho Wang

November 26, 2024

The West Taiwan team was recently awarded the Work-Life Balance Award by the Ministry of Labor, Republic of China (Taiwan). This accolade highlights our ongoing commitment to creating a supportive and flexible work environment that prioritizes the well-being of our team members and fosters a culture of trust and innovation.